Search the Newsreel

NRB Bearings Publishes Q1 FY2026-27 Earnings Call Audio for Investors

Biomarin Pharmaceutical stock hits 52-week high at 66.28 USD

BioMarin Pharmaceutical (BMRN) stock reached a new 52-week high of $66.28, reflecting a 16.44% increase over the past year. InvestingPro analysis suggests the stock is undervalued with strong fundamentals, including 11.2% revenue growth. The company also reported impressive Q2 2026 results, exceeding Wall Street …

BioMarin Pharmaceutical Aktie erreicht 52-Wochen-Hoch bei 66,28 USD

Shareholder Alert: Ademi LLP investigates whether MarineMax, Inc. is obtaining a Fair Price for Public Shareholders

Ademi LLP is investigating MarineMax (NYSE: HZO) regarding potential breaches of fiduciary duty related to its recently announced $1.5 billion all-cash transaction with Safe Harbor Marinas. The firm is examining whether the $53.00 per share offer represents a fair price for public shareholders, especially …

HZO Stock Alert: Halper Sadeh LLC is Investigating Whether MarineMax, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of MarineMax, Inc. (NYSE: HZO) to Safe Harbor Marinas for $53.00 per share in cash. The firm is examining whether MarineMax and its board failed to secure the best possible price for …

Should Value Investors Buy Barings BDC (BBDC) Stock?

Barings BDC (BBDC) is presented as a strong value stock due to its favorable Zacks Rank #2 (Buy) and Value grade of A. The article highlights BBDC's attractive P/E, P/B, and P/CF ratios compared to its industry averages, suggesting it is currently undervalued. Investors …

BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston

SAN RAFAEL, Calif., Aug. 10, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced management will present at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston.BioMarin Pharmaceutical logo An audio webcast of the presentation …

Knowledge Marine & Engineering Works wins Rs 11.41 crore work order from Paradip Port Authority

BioMarin presentation to stream live from Boston on Aug. 12

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced it will present at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00 AM ET in Boston. A live audio webcast and a limited-time archived replay will be available on the company's investor …

Canaccord raises BioMarin stock price target on revenue growth

Canaccord has increased its price target for BioMarin Pharmaceutical Inc. (BMRN) to $114 from $111, maintaining a Buy rating, following strong second-quarter 2026 earnings. The company's revenue growth was significantly boosted by the acquisition of GALAFOLD and POMBILITI + OPFOLDA, leading to raised fiscal …

Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout

Investing.com - U.S. stock index futures edged higher on Monday, while Dow futures were little changed, as investors scaled back hopes for a breakthrough in the Middle East and looked ahead to key inflation data due later this week for fresh clues on the …

MarineMax soars after agreeing to a go-private deal

[3D Growth Graph on Blueprint with Measurement Tools Illustrating Planning and Progress] J Studios MarineMax (HZO [https://seekingalpha.com/symbol/HZO]) announced on Monday that it accepted a buyout offer from Safe Harbor at $53.00 per share. The all-cash transaction represents an enterprise value of approximately $1.5B. The …

MarineMax, Inc. (NYSE:HZO) Given Average Rating of "Moderate Buy" by Brokerages

Is RBC Bearings (RBC) Pricey On Strong Earnings And Higher Guidance?

Barinthus Biotherapeutics plc Revenue Breakdown – NASDAQ:BRNS

BioMarin (BMRN) Is Up 6.3% After Raising 2026 Revenue Guidance And Highlighting Voxzogo Momentum

Amundi Sells 9,461 Shares of RBC Bearings Incorporated $RBC

Amarin Corporation PLC (AMRN) Earnings Forecast: Future EPS & Revenue Growth Estimates

If You Invested $1000 In RBC Bearings Stock 15 Years Ago, You Would Have This Much Today

RBC Bearings (NYSE: RBC) has significantly outperformed the market over the last 15 years, achieving an average annual return of 20.38%. An initial investment of $1000 in RBC stock 15 years ago would now be worth $16,630.02. This demonstrates the substantial impact of compounded …

Avoiding Lag: Real-Time Signals in (BBDC) Movement

This article provides a real-time analysis of Barings Bdc Inc. (NASDAQ: BBDC) movement, highlighting a near-term strong sentiment but a neutral mid and long-term outlook. AI-generated trading strategies are offered for different risk profiles, including position, momentum breakout, and risk hedging strategies. The analysis …

BioMarin Pharmaceutical Inc. (BMRN.MX) Analyst insights, Price targets and Recommendations

This article provides an overview of recent analyst ratings for BioMarin Pharmaceutical Inc. (BMRN.MX), including upgrades, downgrades, and maintained ratings from various financial institutions. It lists the latest price targets and recommendations from firms like Morgan Stanley, Oppenheimer, and Citigroup, along with the dates …

Beng Kuang Marine (SGX:BEZ) Stock Faces Dilution Overhang Despite DCF Gap

Barings BDC (BBDC) Q2 2023 Earnings Report - Results, Call & Slides

BioMarin Pharmaceutical Inc. Stock 12‑Month Price Target Raised to $89.5, Implies 46% Upside

BioMarin Pharmaceutical Inc.'s average stock price target has been raised to $89.5 from $87.83 by 24 analysts, indicating a potential 46% upside based on the Aug. 6 closing price. The consensus rating from 29 analysts remains "Buy," with 22 Buys, 7 Holds, and no …

Caring Brands Inc (CABR) Stock News Today

This page provides stock news for Caring Brands Inc (CABR), showing its current stock price, market cap, and a note that more news is coming soon. As of the last close, CABR was trading at $1.440, up 7.87%, with a market capitalization of $12.14 …

RBC Bearings Incorporated (RBC) stock price, news, quote and history

This article provides a comprehensive overview of RBC Bearings Incorporated (RBC), including its current stock price, historical performance, key financial metrics, and company profile. It details RBC's product segments in aerospace/defense and industrial applications, and its market presence across various sectors. The report also …

RBC Bearings (NYSE:RBC) Upgraded at Wall Street Zen

Wall Street Zen has upgraded RBC Bearings (NYSE:RBC) from a "hold" to a "buy" rating. This upgrade contributes to an overall "Moderate Buy" sentiment among analysts, with a consensus price target of $623. RBC Bearings recently reported strong quarterly results, exceeding EPS and revenue …

Odyssey Marine Exploration Inc (OMEX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Odyssey Marine Exploration Inc (OMEX), noting that no earnings forecast score is currently available for the company, while the industry average is 7.63. It also includes the latest stock price, market capitalization, and a comparison with peer …

Amarin (AMRN) Q2 2026 Earnings Call Transcript

BioMarin (BMRN) Stock Gains On Higher Outlook Despite Profit Drop

Beng Kuang Marine Limited Reports Earnings Results for the Half Year Ended June 30, 2026

Beng Kuang Marine Lifts 1H Revenue on Engineering Growth as Order Book Signals Stronger 2H

Bank of Marin Bancorp | 10-Q: Q2 2026 Earnings Report

This entry indicates the availability of Bank of Marin Bancorp's 10-Q filing for the second quarter of 2026. A 10-Q report is a comprehensive quarterly financial statement submitted to the SEC by public companies. It provides a detailed overview of the company's financial performance.

BioMarin Pharmaceutical Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:BMRN) 2026-08-07

BioMarin Pharmaceutical's Q2 revenue approached $1 billion, a 20% increase year-over-year, driven by its rare-disease portfolio and the Amicus acquisition. The company raised its full-year guidance for revenue, VOXZOGO revenue, and non-GAAP EPS, projecting significant growth from Amicus therapies and VOXZOGO becoming a $1 …

3 Reasons Why Growth Investors Shouldn't Overlook RBC Bearings (RBC)

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all. That's because, these stocks usually carry above-average risk and volatility. …

Barinthus Biotherapeutics (Nasdaq: BRNS) details Q2 loss, cash and Clywedog merger plan

Barinthus Biotherapeutics (BRNS) reported a Q2 2026 net loss of $10.6 million and a six-month net loss of $16.1 million, improvements over the prior year due to reduced R&D and administrative expenses. The company holds $59.6 million in cash, expected to fund operations for …